The Analyst Landscape: 7 Takes On AnaptysBio
The Analyst Landscape: 7 Takes On AnaptysBio
分析師格局：對AnaptysBio的7種看法
In the preceding three months, 7 analysts have released ratings for AnaptysBio (NASDAQ:ANAB), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有7位分析師發佈了AnaptysBio（納斯達克股票代碼：ANAB）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for AnaptysBio, presenting an average target of $50.0, a high estimate of $80.00, and a low estimate of $28.00. Surpassing the previous average price target of $30.00, the current average has increased by 66.67%.
在對12個月目標股價的評估中，分析師公佈了對AnaptysBio的見解，將平均目標價定爲50.0美元，最高估計爲80.00美元，低估值爲28.00美元。超過了之前的平均目標股價30.00美元，目前的平均價格上漲了66.67％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
A comprehensive examination of how financial experts...
對金融專家如何...
登入免費觀看全文
登入/註冊